Dr Mary Kay Uchmanowicz, CCCA in Smithfield, RI - Medicare Provider

Dr Mary Kay Uchmanowicz, CCCA is a medicare enrolled "Audiologist" provider in Smithfield, Rhode Island. Her current practice location is 151 Douglas Pike, Smithfield, Rhode Island. You can reach out to her office (for appointments etc.) via phone at (401) 349-0456.

Dr Mary Kay Uchmanowicz is licensed to practice in Rhode Island (license number AUD00085) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1700899986.

Contact Information

	Dr Mary Kay Uchmanowicz, CCCA
	151 Douglas Pike, Smithfield, RI 02917
	(401) 349-0456
	(401) 349-0457

Healthcare Provider's Profile

Full Name	Dr Mary Kay Uchmanowicz
Gender	Female
Speciality
Experience	Years
Location	151 Douglas Pike, Smithfield, Rhode Island
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mary Kay Uchmanowicz attended and graduated from in

NPI Data:

NPI Number: 1700899986
Provider Enumeration Date: 08/15/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Mary Kay Uchmanowicz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1700899986	NPI	-	NPPES
AUD00085	Other		RI LICENSE
235174	Other		BLUE SHIELD OF RI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	AUD00085 (Rhode Island)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mary Kay Uchmanowicz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mary Kay Uchmanowicz, CCCA 151 Douglas Pike, Smithfield, RI 02917 Ph: (401) 349-0456	Dr Mary Kay Uchmanowicz, CCCA 151 Douglas Pike, Smithfield, RI 02917 Ph: (401) 349-0456

News Archive

Mouse models demonstrate new potential target in fight against Alzheimer's disease

Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.

Study underscores challenges faced by people with food allergy in making safe food choices

A study found that consumers with food allergy concerns often misunderstand food labels about allergens that say "may contain" or "manufactured on shared equipment." While they should avoid such products to prevent what could be a serious allergic reaction, up to 40 percent bought food items with precautionary allergen labels.

Meningitis B vaccine on the horizon

Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.

Women's community groups help reduce neonatal mortality rates

Women's community groups have had a dramatic effect on reducing neonatal mortality rates in some of the poorest areas on India, according to a study published today in the journal the Lancet. The groups provide a cost-effective intervention with added benefits such as reducing significantly maternal depression and improving decision-making amongst the women.

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced today that it has made significant progress with its proprietary Cobalamin-targeted drug-delivery program for siRNA therapies.

Dr Mary Kay Uchmanowicz, CCCA - Medicare Audiologist in Smithfield, RI